Q2 2026 results showed higher revenue but lower margins and earnings due to project timing and margin pressure in healthcare and institutional markets. Strong bookings and the CYMCOR acquisition support a diversified growth strategy, with revised guidance reflecting near-term headwinds.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.